Holen Sie sich die Stockscreener-App
1.895
10.25%
0.175
Schlusskurs vom Vortag:
$1.72
Offen:
$1.73
24-Stunden-Volumen:
5.02M
Relative Volume:
0.85
Marktkapitalisierung:
$994.98M
Einnahmen:
$1.92B
Nettoeinkommen (Verlust:
$-85.55M
KGV:
-11.40
EPS:
-0.1663
Netto-Cashflow:
$-68.98M
1W Leistung:
+10.25%
1M Leistung:
-5.18%
6M Leistung:
-27.62%
1J Leistung:
-43.05%
1-Tages-Spanne:
$1.73
$1.93
1-Wochen-Bereich:
$1.58
$1.93
52-Wochen-Spanne:
$1.58
$3.92
Clover Health Investments Corp Stock (CLOV) Company Profile
Firmenname
Clover Health Investments Corp
Sektor
Branche
Telefon
(201) 432-2133
Adresse
30 MONTGOMERY STREET, JERSEY CITY
Compare CLOV vs UNH, CVS, CI, ELV, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLOV
Clover Health Investments Corp
|
1.8964 | 902.43M | 1.92B | -85.55M | -68.98M | -0.1663 |
UNH
Unitedhealth Group Inc
|
281.27 | 251.66B | 447.57B | 12.81B | 16.08B | 13.19 |
CVS
Cvs Health Corp
|
73.43 | 93.49B | 402.11B | 1.73B | 7.81B | 1.3835 |
CI
Cigna Group
|
275.14 | 71.19B | 274.88B | 6.29B | 8.39B | 22.19 |
ELV
Elevance Health Inc
|
304.85 | 66.06B | 199.13B | 5.66B | 3.17B | 25.11 |
HUM
Humana Inc
|
182.68 | 21.35B | 129.66B | 1.20B | 375.00M | 9.8083 |
Clover Health Investments Corp Stock (CLOV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-17 | Eingeleitet | Craig Hallum | Buy |
| 2024-10-07 | Eingeleitet | UBS | Neutral |
| 2022-02-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-02-02 | Hochstufung | Cowen | Underperform → Market Perform |
| 2022-01-19 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2022-01-10 | Fortgesetzt | Citigroup | Neutral |
| 2022-01-07 | Herabstufung | Credit Suisse | Neutral → Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Underperform |
| 2021-09-02 | Fortgesetzt | Citigroup | Neutral |
| 2021-07-12 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-06-10 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-05-17 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-03-09 | Eingeleitet | Credit Suisse | Neutral |
| 2021-02-02 | Eingeleitet | Citigroup | Buy |
| 2021-02-01 | Eingeleitet | JP Morgan | Neutral |
Alle ansehen
Clover Health Investments Corp Aktie (CLOV) Neueste Nachrichten
CLOV Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Clover Health Investments Corp (CLOV) Unveils Availity Essential for Administrative Tasks - MSN
Clover Health (CLOV) executive receives 191,261 RSUs vesting through 2030 - Stock Titan
Clover Health (CLOV) grants 159,384 RSU-based shares to Medicare Advantage CEO - Stock Titan
Clover Health (CLOV) CEO gets RSU grant; shares withheld for taxes - Stock Titan
Clover Health (CLOV) executive granted 267,766 RSUs and reports large share holdings - Stock Titan
Clover Health (CLOV) awards 382,522 RSUs to Chief Legal Officer - Stock Titan
Clover Health Moves from Pledge to Production, Becomes the First Payer Live on A CMS Aligned Network - marketscreener.com
Clover Health becomes first payer live on CMS aligned network - Investing.com
Clover Health Investments, Corp. (CLOV) latest stock news and headlines - Yahoo Finance Singapore
Clover Health Investments Insiders Placed Bullish Bets Worth US$1.07m - Yahoo Finance
CLOV Stock Price, Quote & Chart | CLOVER HEALTH INVESTMENTS CO (NASDAQ:CLOV) - ChartMill
Clover Health Inv Stock: Navigating Medicare Advantage Growth and Operational Challenges for North A - AD HOC NEWS
Clover Health Investments Corp (7QD.MU) Balance Sheet - Yahoo! Finance Canada
Clover Health CFO Peter Kuipers steps down, Clay Thornton named interim - Investing.com Australia
Clover Health Investments (NASDAQ:CLOV) Stock Price Down 8.8%Should You Sell? - MarketBeat
Clover Health Announces CFO Transition and Reaffirms 2026 Outlook - TipRanks
Clover Health Investments, Corp. Announces Chief Financial Officer Changes - marketscreener.com
Clover Health Announces Departure of Chief Financial Officer and Appointment of Interim Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for Full Fiscal Year 2026 - bitget.com
Clover Health (CLOV) shifts CFO role, appoints interim finance chief and reaffirms 2026 guidance - Stock Titan
CLOV.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Clover Health Investments Corp. (US18914F1030.SG) Stock Price, News, Quote & History - Yahoo! Finance Canada
Clover Health Investments (NASDAQ:CLOV) Reaches New 52-Week LowHere's What Happened - MarketBeat
Clover Health Investments (CLOV) price target decreased by 10.92% to 2.60 - MSN
MedTech's Edge: How AI and Remote Diagnostics Drive Scalable Value - Benzinga
Clover Health Investments, Corp. (NASDAQ:CLOV) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Vanguard amends Schedule 13G/A; reports 0 shares in Clover Health (CLOV) - stocktitan.net
Clover Health Inv stock faces renewed scrutiny amid Medicare Advantage pricing pressures and Q1 enro - AD HOC NEWS
Tranche Update on Clover Health Investments, Corp.'s Equity Buyback Plan announced on May 7, 2024. - marketscreener.com
Clover Health Investments (NASDAQ:CLOV) Hits New 52-Week Low After Analyst Downgrade - MarketBeat
Earnings Recap: Will Clover Health Investments Corp benefit from geopolitical trends2026 Update & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Published on: 2026-03-22 02:36:37 - baoquankhu1.vn
Canaccord Lowers Clover Health (CLOV) Price Target to $3.20, Mai - GuruFocus
Canaccord Genuity Group Has Lowered Expectations for Clover Health Investments (NASDAQ:CLOV) Stock Price - MarketBeat
Clover Health (CLOV) Subsidiary Enhances Flu Vaccination and Red - GuruFocus
Counterpart Assistant Linked to Fewer Flu-Related Acute Care Events for COPD and CHF Patients - National Today
When doctors used this AI prompt, high-risk patients had fewer flu ER trips - Stock Titan
Insider Sell: Jamie Reynoso Sells Shares of Clover Health Investments Corp (CLOV) - GuruFocus
Clover Health: Strong Growth, Improving Margins, And A Mispriced Stock (NASDAQ:CLOV) - Seeking Alpha
Clover Health Investments Stock (ISIN: US18914F1030) Faces Medicare Headwinds Amid Clover Health Tur - AD HOC NEWS
Clover Health CEO Reynoso sells $11,141 in shares By Investing.com - Investing.com Australia
Clover Health CEO Reynoso sells $11,141 in shares - Investing.com
Clover Health (CLOV) Medicare Advantage CEO sells 5,833 shares in planned trade - Stock Titan
CLOV (NASDAQ: CLOV) Form 144 shows 5,833 RSUs proposed sale; prior 10b5-1 sales listed - Stock Titan
Clover Health Investments (CLOV) price target decreased by 11.47% to 2.92 - MSN
Clover Health stock hits 52-week low at $1.92 By Investing.com - Investing.com South Africa
Sentiment Review: What is the Moat Score of Clover Health Investments CorpWeekly Stock Analysis & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
Clover Health (CLOV) exec Reynoso has shares withheld to cover RSU tax obligations - Stock Titan
RSU vesting triggers tax share withholding at Clover Health (CLOV) - Stock Titan
Clover Health (CLOV) CEO has shares withheld to cover RSU taxes - Stock Titan
Clover Health stock hits 52-week low at $1.92 - Investing.com
Finanzdaten der Clover Health Investments Corp-Aktie (CLOV)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.72%
4.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):